Ling-Ming Tseng

3.9k total citations
3 papers, 38 citations indexed

About

Ling-Ming Tseng is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Ling-Ming Tseng has authored 3 papers receiving a total of 38 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Oncology, 2 papers in Cancer Research and 1 paper in Surgery. Recurrent topics in Ling-Ming Tseng's work include Cancer Treatment and Pharmacology (2 papers), Breast Cancer Treatment Studies (2 papers) and Complementary and Alternative Medicine Studies (1 paper). Ling-Ming Tseng is often cited by papers focused on Cancer Treatment and Pharmacology (2 papers), Breast Cancer Treatment Studies (2 papers) and Complementary and Alternative Medicine Studies (1 paper). Ling-Ming Tseng collaborates with scholars based in Taiwan. Ling-Ming Tseng's co-authors include Po‐Min Chen, Weishu Wang, Liu H, Li‐Yin Chien, Cheng-Jeng Tai, Sheng‐Miauh Huang and Chi‐Cheng Huang and has published in prestigious journals such as Evidence-based Complementary and Alternative Medicine, Investigational New Drugs and Journal of Plastic Reconstructive & Aesthetic Surgery.

In The Last Decade

Ling-Ming Tseng

2 papers receiving 37 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ling-Ming Tseng Taiwan 2 19 11 11 9 8 3 38
Nada Elzahed United Kingdom 2 15 0.8× 8 0.7× 11 1.0× 15 1.7× 4 0.5× 2 41
Wang Aiying China 4 7 0.4× 9 0.8× 8 0.7× 21 2.3× 2 0.3× 10 82
Zhiquan Zhao China 2 12 0.6× 3 0.3× 12 1.1× 4 0.4× 5 0.6× 2 26
Yiwen Sun China 5 12 0.6× 10 0.9× 19 1.7× 25 2.8× 16 2.0× 12 75
Chen Tan China 5 6 0.3× 10 0.9× 16 1.5× 12 1.3× 3 0.4× 6 48
R. Nair India 5 47 2.5× 7 0.6× 36 3.3× 33 3.7× 20 2.5× 15 101
Zoë Fuchs United States 2 36 1.9× 7 0.6× 22 2.0× 24 2.7× 2 0.3× 4 56
Midori Kubota Japan 6 10 0.5× 9 0.8× 14 1.3× 7 0.8× 9 74
Alberto Martín‐Lorenzo Spain 3 8 0.4× 8 0.7× 15 1.4× 20 2.2× 3 0.4× 6 40
Q. T. Tao China 4 3 0.2× 11 1.0× 15 1.4× 10 1.1× 7 0.9× 9 90

Countries citing papers authored by Ling-Ming Tseng

Since Specialization
Citations

This map shows the geographic impact of Ling-Ming Tseng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling-Ming Tseng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling-Ming Tseng more than expected).

Fields of papers citing papers by Ling-Ming Tseng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling-Ming Tseng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling-Ming Tseng. The network helps show where Ling-Ming Tseng may publish in the future.

Co-authorship network of co-authors of Ling-Ming Tseng

This figure shows the co-authorship network connecting the top 25 collaborators of Ling-Ming Tseng. A scholar is included among the top collaborators of Ling-Ming Tseng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling-Ming Tseng. Ling-Ming Tseng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

3 of 3 papers shown
1.
Huang, Chi‐Cheng, et al.. (2024). Automatic segmentation of MRI in prospective breast volume evaluation: Comparison of different assessments for immediate breast reconstruction. Journal of Plastic Reconstructive & Aesthetic Surgery. 95. 273–282.
2.
Huang, Sheng‐Miauh, et al.. (2013). Increases in Xu Zheng and Yu Zheng among Patients with Breast Cancer Receiving Different Anticancer Drug Therapies. Evidence-based Complementary and Alternative Medicine. 2013. 1–8. 5 indexed citations
3.
Tseng, Ling-Ming, et al.. (2005). Paclitaxel in a novel formulation containing less Cremophor EL as first-line therapy for advanced breast cancer: A phase II trial. Investigational New Drugs. 23(2). 171–177. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026